Lymphocyte characteristics in rheumatic patients and the effect of azathioprine therapy.
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology*; D001379:Azathioprine / Q000494:pharmacology* / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D002499:Centrifugation, Density Gradient; D002986:Clinical Trials as Topic; D004912:Erythrocytes / Q000276:immunology; D006801:Humans; D007104:Immune Adherence Reaction; D037102:Lectins / Q000494:pharmacology; D007958:Leukocyte Count; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D008214:Lymphocytes / Q000187:drug effects* / Q000276:immunology; D008722:Methods; D011565:Psoriasis / Q000188:drug therapy / Q000276:immunology; D012756:Sheep; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D037102:Lectins; D001379:Azathioprine